Publication: Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity
Issued Date
2021-07-01
Resource Type
ISSN
24680249
Other identifier(s)
2-s2.0-85107719483
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Kidney International Reports. Vol.6, No.7 (2021), 1912-1922
Suggested Citation
Ngoentra Tantranont, Yosu Luque, Mary Hsiao, Claire Haute, Lillian Gaber, Roberto Barrios, Horacio E. Adrogue, Aïssata Niasse, Luan D. Truong Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity. Kidney International Reports. Vol.6, No.7 (2021), 1912-1922. doi:10.1016/j.ekir.2021.04.035 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/78091
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity
Abstract
Introduction: Vancomycin nephrotoxicity is frequent and may be due to drug-induced acute tubular necrosis (ATN) or tubulointerstitial nephritis (TIN). Vancomycin-associated tubular cast (VTC) was recently described and may represent a novel cause of vancomycin nephrotoxicity. However, much is still unknown about VTC. Materials and Methods: Thirty-seven kidney biopsy specimens from patients who were treated with vancomycin and developed acute kidney injury (AKI) were found among a total of 4673 biopsy samples between 2010 and 2019. These biopsy specimens were subjected to light microscopy, immunofluorescence, electron microscopy, and immunolocalization for vancomycin, uromodulin, myoglobin, tubular segment–specific markers, and examined for VTCs. The findings were correlated with the clinical course. Results: VTCs displayed precipitated vancomycin casts in a background of uromodulin; the casts were limited to the distal tubules, and always associated with a background of more diffuse renal injury (ATN or TIN). The diagnosis of vancomycin nephrotoxicity was made in in 28 of 37 patients. VTC was noted in 25 of 28 biopsy samples from patients diagnosed with vancomycin nephrotoxicity and in one of nine biopsy samples from patients without this diagnosis. Vancomycin nephrotoxicity was diagnosed in 25 of 26 patients whose biopsy specimens showed VTC, but in only 3 of 11 patients without VTC in the biopsy samples. Conclusions: VTC displays a characteristic morphologic profile amenable to ready recognition in biopsy specimens. It results from coprecipitation of vancomycin and uromodulin. It facilitates the biopsy diagnosis of vancomycin nephrotoxicity. It may have a nephrotoxic effect superimposing on and independent from the ATN or interstitial nephritis in the pathogenesis of vancomycin nephrotoxicity.